Investors considering a purchase of Krystal Biotech Inc (Symbol: KRYS ... Collecting that bid as the premium represents a 9.1% return against the $150 commitment, or a 16.3% annualized rate ...

Matador Technologies Inc. ("Matador" or the "Company") , a Bitcoin Ecosystem company, is pleased to announce that the Company's stock ticker symbol on the OTCQB Venture Market (the "OTCQB") will ...

(NEPC). The findings enhance the understanding of the treatment of androgen receptor functions in NEPC. Neuroendocrine prostate cancer (NEPC) arises primarily through neuroendocrine ...

BioSyent Inc. ("BioSyent", TSX Venture: RX) is pleased to announce that it will be presenting at the upcoming 2025 Bloom Burton & Co. Healthcare Investor Conference. The conference will be held in ...

FRONTIER Space recently achieved a major milestone with the successful launch of its fully automated laboratory demonstrator aboard SpaceX’s Bandwagon-3 mission on April 22, in partnership with ATMOS ...

Merck KGaA plans to acquire SpringWorks Therapeutics (NASDAQ:SWTX) for approximately $3.9 billion, aiming to enhance its ...

Discover why Community Healthcare Trust (CHCT) remains attractively valued despite challenges. Read more here.

Legend Biotech faces a 60% stock drop amid safety, supply issues, and competition for its CAR-T therapy, Carvykti. See here ...

The quiet rise of K18—a premium haircare brand with a scientific soul—offers a textbook case of what modern consumers want, and what luxury brands must now deliver. Not louder claims. Not flashier ...

Krystal Biotech, Inc. (the "Company”) (NASDAQ: KRYS) announced today that on April 23, 2025, the European Commission (EC) granted marketing authorization to VYJUVEK ® (beremagene geperpavec-svdt) for ...